Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia

Journal of the Neurological Sciences

Volumn 266, Issue 1-2, 2008, Pages 57-62

  Gackowski, Daniel ^a   Rozalski, Rafal ^a   Siomek, Agnieszka ^a   Dziaman, Tomasz ^a   Nicpon, Krzysztof ^b   Klimarczyk, Maciej ^a   Araszkiewicz, Aleksander ^a   Olinski, Ryszard ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b E Warminski City Hospital   (Poland)

Author keywords

Alzheimer disease; Antioxidants; Cerebrospinal fluid; Mixed dementia; Oxidative damage to DNA; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 HYDROXYGUANINE; ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; RETINOL; URIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; MULTIINFARCT DEMENTIA; OXIDATIVE STRESS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIOXIDANTS; ASCORBIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEMENTIA, VASCULAR; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OXIDATIVE STRESS; URIC ACID; VITAMIN A; VITAMIN E;

EID: 38749084157     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.08.041     Document Type: Article

References (34)

1. Huang X., Moir R.D., Tanzi R.E., Bush A.I., and Rogers J.T. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann N Y Acad Sci 1012 (2004) 153-163
2. Leutner S., Schindowski K., Frolich L., Maurer K., Kratzsch T., Eckert A., et al. Enhanced ROS-generation in lymphocytes from Alzheimer's patients. Pharmacopsychiatry 38 (2005) 312-315
3. Markesbery W.R., and Carney J.M. Oxidative alterations in Alzheimer's disease. Brain Pathol 9 (1999) 133-146
4. Migliore L., Petrozzi L., Lucetti C., Gambaccini G., Bernardini S., Scarpato R., et al. Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients. Neurology 58 (2002) 1809-18015
5. Migliore L., Fontana I., Trippi F., Colognato R., Coppede F., Tognoni G., et al. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging 26 (2005) 567-573
6. Suzuki J., Inoue Y., and Suzuki S. Changes in the urinary excretion level of 8-hydroxyguanine by exposure to reactive oxygen-generating substances. Free Radic Biol Med 18 (1995) 431-436
7. Shigenaga M.K., Gimeno C.J., and Ames B.N. Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci U S A 86 (1989) 9697-9701
8. Cooke M.S., Evans M.D., Herbert K.E., and Lunec J. Urinary 8-oxo-2'-deoxyguanosine-source, significance and supplements. Free Radic Res 32 (2000) 381-397
9. Olinski R., Rozalski R., Gackowski D., Foksinski M., Siomek A., and Cooke M.S. Urinary measurement of 8-OxodG, 8-OxoGua, and 5HMUra: a noninvasive assessment of oxidative damage to DNA. Antioxid Redox Signal 8 (2006) 1011-1019
10. Loft S., and Poulsen H.E. Estimation of oxidative DNA damage in man from urinary excretion of repair products. Acta Biochim Pol 45 (1998) 133-144
11. Hayakawa H., Taketomi A., Sakumi K., Kuwano M., and Sekiguchi M. Generation and elimination of 8-oxo-7,8-dihydro-2'-deoxyguanosine 5′-triphosphate, a mutagenic substrate for DNA synthesis, in human cells. Biochemistry 34 (1995) 89-95
12. Gackowski D., Rozalski R., Roszkowski K., Jawien A., Foksinski M., and Olinski R. 8-Oxo-7,8-dihydroguanine and 8-oxo-7,8-dihydro-2'-deoxyguanosine levels in human urine do not depend on diet. Free Radic Res 35 (2001) 825-832
13. Rockwood K. Mixed dementia: Alzheimer's and cerebrovascular disease. Int Psychogeriatr 15 Suppl 1 (2003) 39-46
14. Nagata K., Saito H., Ueno T., Sato M., Nakase T., Maeda T., et al. Clinical diagnosis of vascular dementia. J Neurol Sci 257 (2007) 44-48
15. Langa K.M., Foster N.L., and Larson E.B. Mixed dementia: emerging concepts and therapeutic implications. JAMA 292 (2004) 2901-2908
16. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
17. Bialkowski K., and Kasprzak K.S. A novel assay of 8-oxo-2'-deoxyguanosine 5′-triphosphate pyrophosphohydrolase (8-oxo-dGTPase) activity in cultured cells and its use for evaluation of cadmium(II) inhibition of this activity. Nucleic Acids Res 26 (1998) 3194-3201
18. Rozalski R., Winkler P., Gackowski D., Paciorek T., Kasprzak H., and Olinski R. High concentrations of excised oxidative DNA lesions in human cerebrospinal fluid. Clin Chem 49 (2003) 1218-1221
19. Dizdaroglu M. Chemical determination of oxidative DNA damage by gas chromatography-mass spectrometry. Methods Enzymol 234 (1994) 3-16
20. Siomek A., Gackowski D., Rozalski R., Dziaman T., Szpila A., Guz J., et al. Higher leukocyte 8-oxo-7,8-dihydro-2'-deoxyguanosine and lower plasma ascorbate in aging humans?. Antioxid Redox Signal 9 (2007) 143-150
21. Markesbery W.R., and Lovell M.A. DNA oxidation in Alzheimer's disease. Antioxid Redox Signal 8 (2006) 2039-2045
22. Mukai K., Nishimura M., and Kikuchi S. Stopped-flow investigation of the reaction of vitamin C with tocopheroxyl radical in aqueous triton X-100 micellar solutions. The structure-activity relationship of the regeneration reaction of tocopherol by vitamin C. J Biol Chem 266 (1991) 274-278
23. Frei B., England L., and Ames B.N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 86 (1989) 6377-6381
24. Sharma M.K., and Buettner G.R. Interaction of vitamin C and vitamin E during free radical stress in plasma: an ESR study. Free Radic Biol Med 14 (1993) 649-653
25. Rose R.C. Cerebral metabolism of oxidized ascorbate. Brain Res 628 (1993) 49-55
26. Agus D.B., Gambhir S.S., Pardridge W.M., Spielholz C., Baselga J., Vera J.C., et al. Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest 100 (1997) 2842-2848
27. Park E.M., Shigenaga M.K., Degan P., Korn T.S., Kitzler J.W., Wehr C.M., et al. Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column. Proc Natl Acad Sci U S A 89 (1992) 3375-3379
28. Klein J.A., Longo-Guess C.M., Rossmann M.P., Seburn K.L., Hurd R.E., Frankel W.N., et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 419 (2002) 367-374
29. Andersen J.K. Oxidative stress in neurodegeneration: cause or consequence?. Nat Med 10 Suppl (2004) S18-S25
30. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., and Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98 (1996) 2572-2579
31. Djordjevic T., Pogrebniak A., BelAiba R.S., Bonello S., Wotzlaw C., Acker H., et al. The expression of the NADPH oxidase subunit p22phox is regulated by a redox-sensitive pathway in endothelial cells. Free Radic Biol Med 38 (2005) 616-630
32. Park L., Anrather J., Zhou P., Frys K., Pitstick R., Younkin S., et al. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 25 (2005) 1769-1777
33. Zingg J.M., and Azzi A. Non-antioxidant activities of vitamin E. Curr Med Chem 11 (2004) 1113-1133
34. Shi J., Perry G., Smith M.A., and Friedland R.P. Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging 21 (2000) 357-361